de Moreno de LeBlanc A., Matar C., Perdigón G. The application of probiotics in cancer.. „The British journal of nutrition”, s. S105–10, październik 2007. DOI: 10.1017/S0007114507839602. PMID: 17922945.
nih.gov
ncbi.nlm.nih.gov
SandrineS.GraffSandrineS. i inni, Influence of pH conditions on the viability of Saccharomyces boulardii yeast, „The Journal of General and Applied Microbiology”, 54 (4), 2008, s. 221–227, ISSN0022-1260, PMID: 18802321 [dostęp 2018-06-14].
de Moreno de LeBlanc A., Matar C., Perdigón G. The application of probiotics in cancer.. „The British journal of nutrition”, s. S105–10, październik 2007. DOI: 10.1017/S0007114507839602. PMID: 17922945.
Rafter J. Probiotics and colon cancer.. „Best practice & research. Clinical gastroenterology”. 5 (17), s. 849–59, październik 2003. PMID: 14507593.
Geier MS., Butler RN., Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?. „Cancer biology & therapy”. 10 (5), s. 1265–9, październik 2006. PMID: 16969130.
Matsuzaki T., Takagi A., Ikemura H., Matsuguchi T., Yokokura T. Intestinal microflora: probiotics and autoimmunity.. „The Journal of nutrition”. 3 Suppl 2 (137), s. 798S–802S, marzec 2007. PMID: 17311978.
SandrineS.GraffSandrineS. i inni, Influence of pH conditions on the viability of Saccharomyces boulardii yeast, „The Journal of General and Applied Microbiology”, 54 (4), 2008, s. 221–227, ISSN0022-1260, PMID: 18802321 [dostęp 2018-06-14].